Patents by Inventor Yoshi Yakushijin

Yoshi Yakushijin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7858742
    Abstract: The invention provides isolated nucleic acids molecules, designated BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a BAL gene has been introduced or disrupted. The invention still further provides isolated BAL proteins, fusion proteins, antigenic peptides and anti-BAL antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Grant
    Filed: August 16, 2004
    Date of Patent: December 28, 2010
    Assignee: Dana-Farber Cancer Institute
    Inventors: Margaret Shipp, Ricardo Aguiar, Yoshi Yakushijin
  • Patent number: 6870040
    Abstract: The invention provides isolated nucleic acids molecules, designated BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a BAL gene has been introduced or disrupted. The invention still further provides isolated BAL proteins, fusion proteins, antigenic peptides and anti-BAL antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: March 22, 2005
    Assignee: Dana-Farber Cancer Institute
    Inventors: Margaret Shipp, Ricardo Aguiar, Yoshi Yakushijin
  • Publication number: 20050014186
    Abstract: The invention provides isolated nucleic acids molecules, designated BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a BAL gene has been introduced or disrupted. The invention still further provides isolated BAL proteins, fusion proteins, antigenic peptides and anti-BAL antibodies. Diagnostic methods using compositions of the invention are also provided.
    Type: Application
    Filed: August 16, 2004
    Publication date: January 20, 2005
    Applicant: Dana-Farber Cancer Institute
    Inventors: Margaret Shipp, Ricardo Aguiar, Yoshi Yakushijin